Lamotte CJA

Language: English
References: 5
Page: 1-4
PDF size: 670.73 Kb.

Text Extraction

To the editor

Despite of coronavirus pandemic with its serious consequences for the world-wide health and the economy in a short time (months), the HIV infection remains by years as a complicated health problem for the world too. But with the great difference the last entity has some successful therapeutics, although there is no cure, a very good control of the infection can be achieved. It is very important to take into account that nowadays all patients should start antiretroviral regimen, no matter his clinical or immunological stage, the tendency is diagnosis and treatment, as early as possible, to avoid the damage to the immunological system by the HIV virus. The goals of this therapy continue being: to get the maximum control of viral replication and to restore the immunodeficiency, so as to prevent the opportunist infections.

REFERENCES

1. Roca Goderich. Temas de Medicina Interna. Tomo llI. 5 ed. La Habana: Editorial Ciencias Médicas, 2017. [citado 17/10/2021]. Disponible en: http://www.bvs.sld.cu/libros_texto/roca_temas_medicina_interna_tomo3_quintaedicion/medicina_internaiii_completo.pdf

2. Lantero Abreu MI, Sánchez Fuentes J, Joanes Fiol J, Betancourt Llody YA, Cancio Enrique I, Matos Morejón MJ, et al. Plan estratégico nacional para la prevención y control de las ITS, el VIH y las hepatitis 2019- 2023. La Habana: Ministerio de Salud Pública, 2019. p. 131-170.

3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. [citado 26/08/2021]: I -22. Aviable at: https://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf

4. Snedecor SJ, Radford M, Kratochvil D, Grove R, Punekar YS. Comparative efficacy and safety of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: a systematic review and network meta-analysis. BMC Infect Dis. 2019 [citado 26/08/2021]; 19(484). Disponible en: https://doi.org/10.1186/s12879-019-3975-6

5. España. GESIDA, Ministerio de sanidad consumo y bienestar social. Documento de consenso de GeSIDA /Plan nacional sobre el sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana. (Actualización enero 2019), [citado 17/10/2021]. Disponible en: https://gesida-seimc.org/wp-content/uploads/2019/01/gesida_DC_TAR_2019_v_final.pdf